Related references
Note: Only part of the references are listed.Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
Matt D. Johansen et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Extreme Drug Tolerance of Mycobacterium abscessus Persisters
Yee-Kuen Yam et al.
FRONTIERS IN MICROBIOLOGY (2020)
Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
Nakwon Kwak et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary Disease
Jianhui Chen et al.
FRONTIERS IN MICROBIOLOGY (2019)
Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model
Graciela Rodriguez-Sevilla et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2018)
Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169)
Andreanne Lupien et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Antimicrobial and Antibiofilm Activity of Synergistic Combinations of a Commercially Available Small Compound Library With Colistin Against Pseudomonas aeruginosa
Nelson S. Torres et al.
FRONTIERS IN MICROBIOLOGY (2018)
A Closer Look at the Genomic Variation of Geographically Diverse Mycobacterium abscessus Clones That Cause Human Infection and Disease
Rebecca M. Davidson
FRONTIERS IN MICROBIOLOGY (2018)
Mycobacterium abscessus WhiB7 Regulates a Species-Specific Repertoire of Genes To Confer Extreme Antibiotic Resistance
Kelley Hurst-Hess et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease
Hayoung Choi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus
Tae Sung Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp abscessus with C-to-T mutation at position 19 in erm(41) gene: case report
Su-Young Kim et al.
BMC INFECTIOUS DISEASES (2016)
A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus
Christian Dupont et al.
MOLECULAR MICROBIOLOGY (2016)
Effect of ciprofloxacin in the ultrastructure and development of biofilms formed by rapidly growing mycobacteria
Maria-Carmen Munoz-Egea et al.
BMC MICROBIOLOGY (2015)
Environmental Sources of Nontuberculous Mycobacteria
Joseph O. Falkinham
CLINICS IN CHEST MEDICINE (2015)
Antiinfectives targeting enzymes and the proton motive force
Xinxin Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase
Maya A. Farha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
Richard J. Wallace et al.
CHEST (2014)
Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection
Sasha J. Rose et al.
PLOS ONE (2014)
Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium tuberculosis Growth
Sarah A. Stanley et al.
PLOS PATHOGENS (2014)
Use of clomiphene citrate in infertile women: a committee opinion
Samantha Pfeifer et al.
FERTILITY AND STERILITY (2013)
Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence
Nuria Andreu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Mycobacterium abscessus: a new antibiotic nightmare
Rachid Nessar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing
Sylvaine Bastian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Importance of antibiotic penetration in the antimicrobial resistance of biofilm formed by non-pigmented rapidly growing mycobacteria against amikacin, ciprofloxacin and clarithromycin
Alberto Ortiz-Perez et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2011)
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
Charles R. Esther et al.
JOURNAL OF CYSTIC FIBROSIS (2010)
Acute Respiratory Failure Involving an R Variant of Mycobacterium abscessus
Emilie Catherinot et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria
Rebecca Greendyke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis
Bodil E. Jonsson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Clomiphene citrate - end of an era? a mini-review
R Homburg
HUMAN REPRODUCTION (2005)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Characterization of biofilm formation by clinical isolates of Mycobacterium avium
G Carter et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis
M Sanguinetti et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Share Paper
